A One Medicine Mission for an Effective Rabies Therapy.

Journal: Frontiers in veterinary science

Volume: 9

Issue: 

Year of Publication: 

Affiliated Institutions:  Department of Biomedical Sciences, Ross University School of Veterinary Medicine, Basseterre, Saint Kitts and Nevis. Department of Medicine, Northern Consultation Centre, Thompson General Hospital, Thompson, MB, Canada. Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australian Animal Health Laboratory at the Australian Centre for Disease Preparedness, Geelong, VIC, Australia. Wistar Institute, Philadelphia, PA, United States. Division of Genetics and Genomics, Easter Bush Veterinary Centre, The Roslin Institute and the Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Roslin, United Kingdom. Canine Rabies Treatment Initiative, Salt Rock, South Africa. Veterinary Anaesthesia, Analgesia and Critical Care Services, Lonehill, South Africa. Department of Neurovirology, WHO Collaborating Centre for Reference and Research in Rabies, National Institute of Mental Health and Neurosciences, Bangalore, India. Veterinary Medical Diagnostic Laboratory, University of Missouri, Columbia, MO, United States. Institut Pasteur de Guinée, Conakry, Guinea. Independent Researcher, Midhurst, United Kingdom. LYSSA LLC, Atlanta, GA, United States.

Abstract summary 

Despite the disease's long history, little progress has been made toward a treatment for rabies. The prognosis for patient recovery remains dire. For any prospect of survival, patients require aggressive critical care, which physicians in rabies endemic areas may be reluctant or unable to provide given the cost, clinical expertise required, and uncertain outcome. Systematic clinical research into combination therapies is further hampered by sporadic occurrence of cases. In this Perspective, we examine the case for a One Medicine approach to accelerate development of an effective therapy for rabies through the veterinary care and investigational treatment of naturally infected dogs in appropriate circumstances. We review the pathogenesis of rabies virus in humans and dogs, including recent advances in our understanding of the molecular basis for the severe neurological dysfunction. We propose that four categories of disease process need to be managed in patients: viral propagation, neuronal degeneration, inflammation and systemic compromise. Compassionate critical care and investigational treatment of naturally infected dogs receiving supportive therapy that mimics the human clinical scenario could increase opportunities to study combination therapies that address these processes, and to identify biomarkers for prognosis and therapeutic response. We discuss the safety and ethics of this approach, and introduce the Canine Rabies Treatment Initiative, a non-profit organization with the mission to apply a One Medicine approach to the investigation of diagnostic, prognostic, and therapeutic options for rabies in naturally infected dogs, to accelerate transformation of rabies into a treatable disease for all patients.

Authors & Co-authors:  Knobel Darryn L DL Jackson Alan C AC Bingham John J Ertl Hildegund C J HCJ Gibson Andrew D AD Hughes Daniela D Joubert Kenneth K Mani Reeta S RS Mohr Bert J BJ Moore Susan M SM Rivett-Carnac Hugh H Tordo Noël N Yeates James W JW Zambelli Anthony B AB Rupprecht Charles E CE

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Tarantola A. Four thousand years of concepts relating to rabies in animals and humans, its prevention and its cure. Trop Med Infect Dis. (2017) 2:5. 10.3390/tropicalmed2020005
Authors :  15
Identifiers
Doi : 867382
SSN : 2297-1769
Study Population
Male,Female
Mesh Terms
Other Terms
blood-brain barrier;canine;immunotherapy;neurodegeneration;pathogenesis;prognosis;rabies;treatment
Study Design
Study Approach
Country of Study
Publication Country
Switzerland